Otto M

Effect of the scale-up of Dolutegravir on retention in care, risk of developing Tuberculosis and viral load suppression among people living with HIV: Analysis of routine HIV clinical data in rural KwaZulu-Natal, South Africa (2019 – 23)
Moyo RC, Okango E, Bolton L, Otto M, Blose N, Letoao NS, Otambo WO, Gareta D, Nyasulu PS, Mee P, Lessels RJ, Tanser FC

Open Forum Infectious Diseases

(2026)

https://doi.org/10.1093/ofid/ofag156
Peer network approaches for improving HIV testing, prevention and care utilisation among men in sub-Saharan Africa: a scoping review
Otambo WO, Harling G, Inghel M, Otto M, Blose N, Tram KH, Tanser FC, Mee P

BMJ Open

(2026)

https://doi.org/10.1136/ bmjopen-2025-106124
Dolutegravir rollout for treatment of HIV with a focus on advanced disease and tuberculosis coinfection: findings from rural KwaZulu-Natal, South Africa (2019– 2023)
Moyo RC, Bolton L, Okango EL, Otto M, Leoao NS, Nyasulu PS, Tanser FC

AIDS Research and Therapy

(2025)

https://doi.org/10.1186/s12981-025-00810-z
High-quality de novo genome assembly and functional genomic insights into Thermobifida alba DSM43795T, a mesophilic actinobacterium isolated from garden soil
Luzics S, Baka E, Otto M, Kosztik J, Szalontai H, Bata-Vidacs I, Nagy I, Toth A, Tancsics A, Papai M, Orsini M, Kukulya J

Biologia Futura

(2025)

https://doi.org/10.1007/s42977-025-00283-1
Trends in population HIV viral suppression: a longitudinal analysis
Otto M, Okango E, Mee P, Dobra A, Tram KH, Gareta D, Otambo WO, Moyo RC, Sereo TD, Blose N, Leoao NS, Mupanguri L, Mwambi H, Herbst K, Tanser FC

AIDS

(2025)

https://doi.org/10.1097/QAD.0000000000004183